Header

UZH-Logo

Maintenance Infos

Mitral Valve Replacement with a Third Generation Porcine Valve: an Italian multicentered study


Lorusso, Roberto; Miceli, Antonio; Gelsomino, Sandro; De Bonis, Michele; Taramasso, Maurizio; et al (2019). Mitral Valve Replacement with a Third Generation Porcine Valve: an Italian multicentered study. Annals of Thoracic Surgery:Epub ahead of print.

Abstract

BACKGROUND
Postoperative outcomes of 3$^{rd}$ generation porcine bioprosthesis for mitral valve replacement (MVR) have been poorly addressed. The objective of this study was to perform an independent, retrospective, multicenter study on outcomes of patients undergoing MVR with Mosaic (Medtronic Inc., Minneapolis, MN) porcine bioposthesis.
METHODS
From 1998 to 2011, 805 patients underwent MVR with Mosaic porcine valve in 11 cardiac centers. There were 465 female patients (58%) and overall mean age was 73.5±7 years. Associated procedures included CABG (201 patients, 24.9%), aortic valve replacement (152 patients, 18.9%), tricuspid annuloplasty (187 patients, 22.3%), and other cardiac procedures (116 patients, 14.4%).
RESULTS
Median follow-up was 44 months (IQR range 16 - 63) with a cumulative duration of 2.769 patient-years. Early mortality for isolated elective MVR was 3.8% (12/313) and overall early mortality was 7.8% (n=63). Rate of late mortality was 3.4% per patient/year (95 late deaths). At 10 years, overall survival was 57.4% (95%CI 48.8%-67.5%) , and cumulative rates of cardiac- and valve-related death were 7.4% (95%CI 4.8%-10.1%) and 1.1% (95%CI 0.2%-1.9%). Ten year cumulative rates of thromboembolic and hemorrhagic events were 6.6% (95CI 1.4%-11.8%)% and 3.9% (95%CI 0.1%-8%) and 10 year cumulative incidence of prosthetic valve endocarditis was 3% (95%CI 1.2%-4.9%). Finally, 10-year cumulative incidence of SVD and reoperations were 5.8% (95% CI 0.2%-11.5%) and 4.8% (95%CI 0.7%-10.3%), respectively.
CONCLUSIONS
This independent, multicenter, retrospective study indicates that Mosaic porcine bioprosthesis for MVR provides satisfactory results in terms of early outcomes and long term outcomes up to 14 years from its implant.

Abstract

BACKGROUND
Postoperative outcomes of 3$^{rd}$ generation porcine bioprosthesis for mitral valve replacement (MVR) have been poorly addressed. The objective of this study was to perform an independent, retrospective, multicenter study on outcomes of patients undergoing MVR with Mosaic (Medtronic Inc., Minneapolis, MN) porcine bioposthesis.
METHODS
From 1998 to 2011, 805 patients underwent MVR with Mosaic porcine valve in 11 cardiac centers. There were 465 female patients (58%) and overall mean age was 73.5±7 years. Associated procedures included CABG (201 patients, 24.9%), aortic valve replacement (152 patients, 18.9%), tricuspid annuloplasty (187 patients, 22.3%), and other cardiac procedures (116 patients, 14.4%).
RESULTS
Median follow-up was 44 months (IQR range 16 - 63) with a cumulative duration of 2.769 patient-years. Early mortality for isolated elective MVR was 3.8% (12/313) and overall early mortality was 7.8% (n=63). Rate of late mortality was 3.4% per patient/year (95 late deaths). At 10 years, overall survival was 57.4% (95%CI 48.8%-67.5%) , and cumulative rates of cardiac- and valve-related death were 7.4% (95%CI 4.8%-10.1%) and 1.1% (95%CI 0.2%-1.9%). Ten year cumulative rates of thromboembolic and hemorrhagic events were 6.6% (95CI 1.4%-11.8%)% and 3.9% (95%CI 0.1%-8%) and 10 year cumulative incidence of prosthetic valve endocarditis was 3% (95%CI 1.2%-4.9%). Finally, 10-year cumulative incidence of SVD and reoperations were 5.8% (95% CI 0.2%-11.5%) and 4.8% (95%CI 0.7%-10.3%), respectively.
CONCLUSIONS
This independent, multicenter, retrospective study indicates that Mosaic porcine bioprosthesis for MVR provides satisfactory results in terms of early outcomes and long term outcomes up to 14 years from its implant.

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Vascular Surgery
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:11 October 2019
Deposited On:10 Jan 2020 07:48
Last Modified:14 Feb 2020 16:38
Publisher:Elsevier
ISSN:0003-4975
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.athoracsur.2019.08.111
PubMed ID:31610166

Download

Full text not available from this repository.
View at publisher

Get full-text in a library